Los Angeles Times

Nexell Stock Triples as FDA OKs Orphan Drug

Nexell Therapeutics Inc. shares more than tripled Wednesday after the Irvine drug maker said it will have seven years of exclusive U.S. marketing rights for an experimental drug to treat a rare ...
The Washington Post

Don't Become An E-Mail Orphan

When David Michelson of Kensington registered seven or eight years ago for an e-mail forwarding account with the Association for Computing Machinery (ACM), he remembers being told that his chosen ...
Los Angeles Times

Artificial Dens for Orphan Cubs

SANTA FE, N.M. — Twenty-five orphaned black bear cubs will be placed in artificial dens during the next two weeks in groups of two or three without mother bears. The idea has never been tried before ...
abc27

ICHNOS SCIENCES RECEIVES ORPHAN DRUG DESIGNATION FOR FIRST-IN-CLASS TRISPECIFIC ANTIBODY, ISB 2001

The U.S. Food and Drug Administration grants orphan drug designation to ISB 2001 for the treatment of multiple myeloma NEW YORK, July 7, 2023 /PRNewswire/ -- Ichnos Sciences Inc., a global ...
Nasdaq

Intellia Therapeutics’ Investigational CRISPR Treatment NTLA-2001 Receives European Union Orphan Drug Designation for ATTR Amyloidosis

CAMBRIDGE, Mass., March 30, 2021 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 ...